Concord Prison Experiment

Last updated
Concord Prison Concord Prison.JPG
Concord Prison

The Concord Prison Experiment, conducted from 1961 to 1963, was designed to evaluate whether the experiences produced by the psychoactive drug psilocybin, derived from psilocybin mushrooms, combined with psychotherapy, could inspire prisoners to leave their antisocial lifestyles behind once they were released. How well it worked was to be judged by comparing the recidivism rate of subjects who received psilocybin with the average for other Concord inmates.

Contents

Staff

Psilocybin acts on the prefrontal cortex of the brain (pictured), a region associated with the personality and with "orchestration of thoughts and actions in accordance with internal goals." Prefrontal cortex.png
Psilocybin acts on the prefrontal cortex of the brain (pictured), a region associated with the personality and with "orchestration of thoughts and actions in accordance with internal goals."

The experiment was conducted between February 1961 and January 1963 in Concord State Prison, a maximum-security prison for young offenders, in Concord, Massachusetts by a team of Harvard University researchers. [2] The team were under the direction of Timothy Leary and included Michael Hollingshead, Allan Cohen, Alfred Alschuder, George Litwin, Ralph Metzner, Gunther Weil, and Ralph Schwitzgebel, with Madison Presnell as the medical and psychiatric adviser. The original study involved the administration of psilocybin manufactured by Sandoz Pharmaceuticals to assist group psychotherapy for 32 prisoners in an effort to reduce recidivism rates. The researchers would administer psilocybin to themselves along with the prisoners, on the grounds of "[creating] a sense of equality and shared experience, and to dispel the fear that often accompanies relationships between [experimenters] and [subjects]". [3]

Results

Records at Concord State Prison suggested that 64 percent of the 32 subjects would return to prison within six months of parole. [4] However, after six months, only 25 percent of those on parole had returned, six for technical parole violations and two for new offenses. Few short-term projects with prisoners have been effective to even a minor degree.[ citation needed ]

In addition, a selection of personality tests were administered to the prisoners both before and after the psilocybin experiences, consisting of the Minnesota Multiphasic Personality Inventory, the California Psychological Inventory, the Maher Sentence Completion Test (designed to measure cynicism in prisoners [5] ), and a Thematic Apperception Test (constructed to measure motives). The personality test scores indicated a measurable positive change when pre-psilocybin and post-psilocybin results were compared. [2]

Follow-up study

The results of this experiment have been largely contested by a follow-up study, citing several problems including differences in the length of time after release that the study group versus the control group were compared, and other methodology factors including the difference between subjects re-incarcerated for parole violations versus imprisoned for new crimes. This study concluded that only a statistically slight improvement could be shown (as opposed to the radical improvement originally reported). In his interview within the study, Leary expressed that the major lesson of the Concord Prison experiment was that the key to a long-term reduction in overall recidivism rates might be the combination of the pre-release administration of psilocybin-assisted group psychotherapy with a comprehensive post-release follow-up program modeled on Alcoholics Anonymous groups to offer support to the released prisoners. The study concluded that whether a new program of psilocybin-assisted group psychotherapy and post-release programs would significantly reduce recidivism rates is an empirical question that deserves to be addressed within the context of a new experiment. [6]

A study by led by Dr. Peter Hendricks at the University of Alabama at Birmingham collected data on 25,622 individuals under community corrections supervision in Treatment Accountability for Safer Communities and found that hallucinogen use predicted a reduced likelihood to fail the TASC program. Results suggested that hallucinogens may promote alcohol and other drug abstinence and prosocial behavior in a population with high rates of recidivism. [7] [8]

See also

Related Research Articles

<span class="mw-page-title-main">Timothy Leary</span> American psychologist (1920–1996)

Timothy Francis Leary was an American psychologist and author known for his strong advocacy of psychedelic drugs. Evaluations of Leary are polarized, ranging from bold oracle to publicity hound. According to poet Allen Ginsberg, he was "a hero of American consciousness", and writer Tom Robbins called him a "brave neuronaut". During the 1960s and 1970s, Leary was arrested 36 times. President Richard Nixon allegedly described him as "the most dangerous man in America".

<span class="mw-page-title-main">Psilocybin</span> Chemical compound found in some species of mushrooms

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of fungi. The most potent are members of genus Psilocybe, such as P. azurescens, P. semilanceata, and P. cyanescens, but psilocybin has also been isolated from about a dozen other genera. Psilocybin is itself biologically inactive but is quickly converted by the body to psilocin, which has mind-altering effects similar, in some aspects, to those of lysergic acid diethylamide (LSD), mescaline, and dimethyltryptamine (DMT). In general, the effects include euphoria, visual and mental hallucinations, changes in perception, distorted sense of time, and perceived spiritual experiences. It can also cause adverse reactions such as nausea and panic attacks.

<span class="mw-page-title-main">Psilocybin mushroom</span> Mushrooms containing psychoactive indole alkaloids

Psilocybin mushrooms, commonly known as magic mushrooms or shrooms, are a polyphyletic informal group of fungi that contain psilocybin, which turns into psilocin upon ingestion. Biological genera containing psilocybin mushrooms include Psilocybe, Panaeolus, Inocybe, Pluteus, Gymnopilus, and Pholiotina.

<span class="mw-page-title-main">Mississippi Department of Corrections</span> State agency that operates prisons

The Mississippi Department of Corrections (MDOC) is a state agency of Mississippi that operates prisons. It has its headquarters in Jackson. As of 2020 Burl Cain is the commissioner.

<span class="mw-page-title-main">Empathogen–entactogen</span> Class of psychoactive drugs that produce empathic experiences

Empathogens or entactogens are a class of psychoactive drugs that induce the production of experiences of emotional communion, oneness, relatedness, emotional openness—that is, empathy or sympathy—as particularly observed and reported for experiences with 3,4-methylenedioxymethamphetamine (MDMA). This class of drug is distinguished from the classes of hallucinogen or psychedelic, and amphetamine or stimulants. Major members of this class include MDMA, MDA, MDEA, MDOH, MBDB, 5-APB, 5-MAPB, 6-APB, 6-MAPB, methylone, mephedrone, GHB, αMT, and αET, MDAI among others. Most entactogens are phenethylamines and amphetamines, although several, such as αMT and αET, are tryptamines. When referring to MDMA and its counterparts, the term MDxx is often used. Entactogens are sometimes incorrectly referred to as hallucinogens or stimulants, although many entactogens such as ecstasy exhibit psychedelic or stimulant properties as well.

Psychedelic therapy refers to the proposed use of psychedelic drugs, such as psilocybin, MDMA, LSD, and ayahuasca, to treat mental disorders. As of 2021, psychedelic drugs are controlled substances in most countries and psychedelic therapy is not legally available outside clinical trials, with some exceptions.

<span class="mw-page-title-main">Recidivism</span> Person repeating an undesirable behavior following punishment

Recidivism is the act of a person repeating an undesirable behavior after they have experienced negative consequences of that behavior, or have been trained to extinguish. It is also used to refer to the percentage of former prisoners who are rearrested for a similar offense.

<span class="mw-page-title-main">Harvard Psilocybin Project</span> Series of psychological research studies into the effects of psychedelics

The Harvard Psilocybin Project was a series of experiments aimed at exploring the effects of psilocybin intake on the human mind conducted by Timothy Leary and Richard Alpert. The founding board of the project consisted of Leary, Aldous Huxley, David McClelland, Frank Barron, Ralph Metzner, and two graduate students who were working on a project with mescaline.

<span class="mw-page-title-main">Marsh Chapel Experiment</span> 1962 psychological research study on religious experiences of psilocybin users

The Marsh Chapel Experiment, also called the "Good Friday Experiment", was an experiment conducted on Good Friday, April 20, 1962 at Boston University's Marsh Chapel. Walter N. Pahnke, a graduate student in theology at Harvard Divinity School, designed the experiment under the supervision of Timothy Leary, Richard Alpert, and the Harvard Psilocybin Project. Pahnke's experiment investigated whether psilocybin would act as a reliable entheogen in religiously predisposed subjects.

Michael Hollingshead (?–1984?) was a British researcher who studied psychedelic drugs, including psilocybin and LSD, at Harvard University in the mid-20th century. He was the father of comedian Vanessa Hollingshead. He evangelized the use of LSD to many notable figures.

<i>High Priest</i> (book)

High Priest is a 1968 book by American psychologist and writer Timothy Leary, published by New American Library. Written before Leary's incarceration on drug-related charges, it is an autobiographical account of his experiences from 1959 to 1962, a period that roughly coincides with his employment as a lecturer in clinical psychology at Harvard University.

Ego death is a "complete loss of subjective self-identity". The term is used in various intertwined contexts, with related meanings. Jungian psychology uses the synonymous term psychic death, referring to a fundamental transformation of the psyche. In death and rebirth mythology, ego death is a phase of self-surrender and transition, as described by Joseph Campbell in his research on the mythology of the Hero's Journey. It is a recurrent theme in world mythology and is also used as a metaphor in some strands of contemporary western thinking.

<span class="mw-page-title-main">Massachusetts Correctional Institution – Concord</span> Prison in Concord, Massachusetts

The Massachusetts Correctional Institution at Concord (MCI-Concord) is a medium security prison for men located in Concord, Massachusetts in the United States. Opened in 1878, it is the oldest running state prison for men in Massachusetts. This prison is under the jurisdiction of the Massachusetts Department of Correction. There are 570 inmates with a total capacity of 614 general population beds.

A prison nursery is a section of a prison that houses incarcerated mothers and their very young children. Prison nurseries are not common in correctional facilities in the United States, although prior to the 1950s many states had them and they are widespread throughout the rest of the world.

The InnerChange Freedom Initiative (IFI) was an American Christian prison program operated by Prison Fellowship International (PFI), a 501(c)(3) nonprofit established by Chuck Colson. The program was closed in 2016.

<span class="mw-page-title-main">Psychoactive drug</span> Chemical substance that alters nervous system function

A psychoactive drug, psychopharmaceutical, psychoactive agent, or psychotropic drug is a chemical substance that changes the function of the nervous system and results in alterations of perception, mood, cognition, and behavior. These substances may be used medically, recreationally, for spiritual reasons, or for research. Some categories of psychoactive drugs may be prescribed by physicians and other healthcare practitioners because of their therapeutic value.

People with mental illnesses are overrepresented in jail and prison populations in the United States relative to the general population. There are three times as many seriously mentally ill people in jails and prisons than in hospitals in the United States, and mentally ill people experience solitary confinement at disproportionate rates compared to the general prison population. There are a number of reasons for this overrepresentation, including the deinstitutionalization of mentally ill individuals in the mid-twentieth century, inadequate community treatment resources, and the criminalization of mental illness itself. There is a consensus that mentally ill offenders have comparable rates of recidivism to non-mentally ill offenders.

Prisoner reentry is the process by which prisoners who have been released return to the community. Many types of programs have been implemented with the goal of reducing recidivism and have been found to be effective for this purpose. Consideration for the conditions of the communities formerly incarcerated individuals are re-entering, which are often disadvantaged, is a fundamental part of successful re-entry.

<span class="mw-page-title-main">Psilocybin therapy</span> Experimental use of psilocybin to treat anxiety & depression

Psilocybin therapy is the use of psilocybin in treating a range of mental health conditions, such as depression, anxiety, addictions, obsessive compulsive disorder, and psychosis. It is one of several forms of psychedelic therapy under study. Psilocybin was popularized as a psychedelic recreational drug in the 1970s and was classified as a Schedule I drug by the DEA. Research on psilocybin as a medical treatment was restricted until the 1990s because of the sociocultural fear of dependence on this drug. As of 2022, psilocybin is the most commonly researched psychedelic due to its safety and low potential for abuse and dependence. Clinical trials are being conducted at universities and there is evidence confirming the use of psilocybin in the treatment of depression, PTSD and end of life anxiety.

Entheogenic drugs have been used by various groups for thousands of years. There are numerous historical reports as well as modern, contemporary reports of indigenous groups using entheogens, chemical substances used in a religious, shamanic, or spiritual context.

References

  1. Miller EK, Freedman DJ, Wallis JD (August 2002). "The prefrontal cortex: categories, concepts and cognition". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 357 (1424): 1123–1136. doi:10.1098/rstb.2002.1099. PMC   1693009 . PMID   12217179.
  2. 1 2 Leary, Timothy; Metzner, Ralph; Presnell, Madison; Weil, Gunther; Schwitzgebel, Ralph; Kinne, Sarah (July 1965). "A New Behavior Change Program Using Psilocybin". Psychotherapy: Theory, Research & Practice. 2 (2): 61–72. CiteSeerX   10.1.1.1022.1124 . doi:10.1037/h0088612.
  3. Leary, Timothy; Litwin, George; Metzner, Ralph (December 1963). "Reactions to psilocybin administered in a supportive environment". The Journal of Nervous and Mental Disease. 137 (6): 561–573. doi:10.1097/00005053-196312000-00007. PMID   14087676. S2CID   39777572.
  4. Metzner, Ralph; Weil, Gunther (September 1963). "Predicting Recidivism: Base-Rates for Massachusetts Correctional Institution Concord". Journal of Criminal Law and Criminology. 54 (3): 307–316. doi:10.2307/1140984. JSTOR   1140984.
  5. Watt, Norman; Maher, Brendan (1959). "Prisoners' Attitudes Toward Home and the Judicial System". Journal of Criminal Law and Criminology. 49 (4): 327–330. doi:10.2307/1141588. JSTOR   1141588.
  6. Doblin, Rick (December 1998). "Dr. Leary's Concord Prison Experiment: A 34-Year Follow-up Study". Journal of Psychoactive Drugs. 30 (4): 419–426. doi:10.1080/02791072.1998.10399715. ISSN   0279-1072. PMID   9924845. S2CID   30462951.
  7. Dolan, Eric W. (2014-01-09). "Take LSD, stay out of prison? Large study links psychedelic use to reduced recidivism". The Raw Story. Archived from the original on 2014-01-13. Retrieved 2021-10-18.
  8. Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision J Psychopharmacol January 2014 vol. 28 no. 1 62-66.